Inmate Central Inmate Central, where civil and family-friendly discourse about off-audio topics (other than religion and politics) is welcome. |
|
In Reply to: Truth.... posted by Ivan303 on November 21, 2020 at 05:40:33:
From your initial response and the Reuters article (which found after reading your response), I got that cost is apparently not the issue. That was not the point of my response to you.The confusion is that you are apparently talking about the antibody drug Regeneron (the one which was used on the President) which has yet to receive an emergency use authorization (EUA). So, you are right about the use of Regeneron. I was talking about the Lilly antibody drug/treatment bamlanivimab which was given an EUA last week by the Food and Drug Administration.
The FDA emergency use authorization (EUA) allows for the investigational monoclonal antibody therapy bamlanivimab to be administered in an outpatient setting (not hospitalized) for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients.
Per FDA: "Bamlanivimab is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19. A benefit of bamlanivimab treatment has not been shown in patients hospitalized due to COVID-19. Monoclonal antibodies, such as bamlanivimab, may be associated with worse clinical outcomes when administered to hospitalized patients with COVID-19 requiring high flow oxygen or mechanical ventilation."
"All thoughts are prey to some beast" - Bill Callahan
"I'll be your mirror
Reflect what you are" - Lou Reed
"Blind belief in authority is the greatest enemy of truth." - Albert Einstein
This post is made possible by the generous support of people like you and our sponsors:
Follow Ups
- RE: Truth.... - Krav Maga 11/21/2010:48:08 11/21/20 (2)
- Yes, they are both only effective if given early... - Ivan303 11:02:19 11/21/20 (1)
- "So who gets the drug?" - Krav Maga 11:54:39 11/21/20 (0)